nodes	percent_of_prediction	percent_of_DWPC	metapath
Formoterol—CYP2D6—Parkinson's disease	0.852	1	CbGaD
Formoterol—Isoprenaline—ADRBK1—Parkinson's disease	0.00541	0.496	CrCbGaD
Formoterol—Dobutamine—COMT—Parkinson's disease	0.00338	0.31	CrCbGaD
Formoterol—Arformoterol—CYP2D6—Parkinson's disease	0.00122	0.112	CrCbGaD
Formoterol—Labetalol—CYP2D6—Parkinson's disease	0.000891	0.0817	CrCbGaD
Formoterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR2A—Parkinson's disease	0.000124	0.000906	CbGpPWpGaD
Formoterol—CYP2D6—Biological oxidations—COMT—Parkinson's disease	0.000124	0.000905	CbGpPWpGaD
Formoterol—CYP2D6—Biological oxidations—GSTP1—Parkinson's disease	0.000124	0.0009	CbGpPWpGaD
Formoterol—CYP2C19—Biological oxidations—GSTM1—Parkinson's disease	0.000124	0.0009	CbGpPWpGaD
Formoterol—CYP2D6—Biological oxidations—MAOA—Parkinson's disease	0.000123	0.000898	CbGpPWpGaD
Formoterol—CYP2C9—Biological oxidations—COMT—Parkinson's disease	0.000123	0.000897	CbGpPWpGaD
Formoterol—CYP2C9—Biological oxidations—GSTP1—Parkinson's disease	0.000123	0.000893	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—DGKQ—Parkinson's disease	0.000123	0.000893	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—GPR37—Parkinson's disease	0.000123	0.000893	CbGpPWpGaD
Formoterol—CYP2D6—Metapathway biotransformation—COMT—Parkinson's disease	0.000123	0.000892	CbGpPWpGaD
Formoterol—ADRB2—GPCR downstream signaling—GRM5—Parkinson's disease	0.000123	0.000892	CbGpPWpGaD
Formoterol—CYP2C9—Biological oxidations—MAOA—Parkinson's disease	0.000122	0.000891	CbGpPWpGaD
Formoterol—ADRB1—Signaling by GPCR—PDYN—Parkinson's disease	0.000122	0.000891	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—GCH1—Parkinson's disease	0.000122	0.00089	CbGpPWpGaD
Formoterol—CYP2D6—Metapathway biotransformation—GSTP1—Parkinson's disease	0.000122	0.000888	CbGpPWpGaD
Formoterol—CYP2C19—Metapathway biotransformation—GSTM1—Parkinson's disease	0.000122	0.000887	CbGpPWpGaD
Formoterol—CYP2C9—Metapathway biotransformation—COMT—Parkinson's disease	0.000122	0.000885	CbGpPWpGaD
Formoterol—CYP2C9—Metapathway biotransformation—GSTP1—Parkinson's disease	0.000121	0.00088	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—DGKQ—Parkinson's disease	0.00012	0.000873	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—GPR37—Parkinson's disease	0.00012	0.000873	CbGpPWpGaD
Formoterol—ADRB2—Signaling by GPCR—PDYN—Parkinson's disease	0.00012	0.000871	CbGpPWpGaD
Formoterol—ADRB1—Signaling by GPCR—GRM5—Parkinson's disease	0.000114	0.000828	CbGpPWpGaD
Formoterol—CYP2D6—Biological oxidations—GSTM1—Parkinson's disease	0.000114	0.000828	CbGpPWpGaD
Formoterol—CYP2C9—Biological oxidations—GSTM1—Parkinson's disease	0.000113	0.00082	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—PPP1R1B—Parkinson's disease	0.000112	0.000816	CbGpPWpGaD
Formoterol—CYP2D6—Metapathway biotransformation—GSTM1—Parkinson's disease	0.000112	0.000816	CbGpPWpGaD
Formoterol—ADRB2—Signaling by GPCR—GRM5—Parkinson's disease	0.000111	0.00081	CbGpPWpGaD
Formoterol—CYP2C9—Metapathway biotransformation—GSTM1—Parkinson's disease	0.000111	0.000809	CbGpPWpGaD
Formoterol—ADRB1—GPCR ligand binding—EDN1—Parkinson's disease	0.000111	0.000806	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—PPP1R1B—Parkinson's disease	0.00011	0.000799	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—FBP1—Parkinson's disease	0.000109	0.000793	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—DBH—Parkinson's disease	0.000109	0.000793	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—GBA—Parkinson's disease	0.000109	0.000793	CbGpPWpGaD
Formoterol—ADRB2—GPCR ligand binding—EDN1—Parkinson's disease	0.000108	0.000789	CbGpPWpGaD
Formoterol—ADRB1—GPCR downstream signaling—ADORA2A—Parkinson's disease	0.000107	0.000775	CbGpPWpGaD
Formoterol—ADRB2—GPCR downstream signaling—ADORA2A—Parkinson's disease	0.000104	0.000758	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—RIT2—Parkinson's disease	9.8e-05	0.000714	CbGpPWpGaD
Formoterol—ADRB1—GPCR ligand binding—HTR2A—Parkinson's disease	9.69e-05	0.000705	CbGpPWpGaD
Formoterol—ADRB1—Signaling by GPCR—ADORA2A—Parkinson's disease	9.67e-05	0.000704	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—RIT2—Parkinson's disease	9.59e-05	0.000698	CbGpPWpGaD
Formoterol—ADRB2—GPCR ligand binding—HTR2A—Parkinson's disease	9.48e-05	0.00069	CbGpPWpGaD
Formoterol—ADRB2—Signaling by GPCR—ADORA2A—Parkinson's disease	9.46e-05	0.000689	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	9.31e-05	0.000677	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—GRK5—Parkinson's disease	9.29e-05	0.000676	CbGpPWpGaD
Formoterol—ADRB1—GPCR downstream signaling—HTR1A—Parkinson's disease	9.24e-05	0.000673	CbGpPWpGaD
Formoterol—ADRB1—GPCR downstream signaling—TAC1—Parkinson's disease	9.1e-05	0.000662	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—GRK5—Parkinson's disease	9.09e-05	0.000662	CbGpPWpGaD
Formoterol—ADRB2—GPCR downstream signaling—HTR1A—Parkinson's disease	9.04e-05	0.000658	CbGpPWpGaD
Formoterol—ADRB1—GPCR downstream signaling—DRD1—Parkinson's disease	8.93e-05	0.00065	CbGpPWpGaD
Formoterol—ADRB2—GPCR downstream signaling—TAC1—Parkinson's disease	8.9e-05	0.000648	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—MCCC1—Parkinson's disease	8.76e-05	0.000638	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—ND3—Parkinson's disease	8.76e-05	0.000638	CbGpPWpGaD
Formoterol—ADRB2—GPCR downstream signaling—DRD1—Parkinson's disease	8.73e-05	0.000635	CbGpPWpGaD
Formoterol—ADRB1—GPCR downstream signaling—DRD3—Parkinson's disease	8.64e-05	0.000629	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	8.49e-05	0.000618	CbGpPWpGaD
Formoterol—ADRB2—GPCR downstream signaling—DRD3—Parkinson's disease	8.46e-05	0.000615	CbGpPWpGaD
Formoterol—ADRB1—Signaling by GPCR—HTR1A—Parkinson's disease	8.39e-05	0.000611	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—GRM4—Parkinson's disease	8.34e-05	0.000607	CbGpPWpGaD
Formoterol—ADRB1—Signaling by GPCR—TAC1—Parkinson's disease	8.26e-05	0.000602	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—TALDO1—Parkinson's disease	8.24e-05	0.0006	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—OMD—Parkinson's disease	8.24e-05	0.0006	CbGpPWpGaD
Formoterol—ADRB2—Signaling by GPCR—HTR1A—Parkinson's disease	8.21e-05	0.000598	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—GRM4—Parkinson's disease	8.15e-05	0.000594	CbGpPWpGaD
Formoterol—ADRB1—Signaling by GPCR—DRD1—Parkinson's disease	8.11e-05	0.00059	CbGpPWpGaD
Formoterol—ADRB2—Signaling by GPCR—TAC1—Parkinson's disease	8.08e-05	0.000588	CbGpPWpGaD
Formoterol—ADRB1—GPCR downstream signaling—ADRBK1—Parkinson's disease	8.07e-05	0.000587	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—ND3—Parkinson's disease	8.06e-05	0.000587	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—MCCC1—Parkinson's disease	8.06e-05	0.000587	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—DDC—Parkinson's disease	8e-05	0.000582	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—ND3—Parkinson's disease	7.99e-05	0.000582	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—MCCC1—Parkinson's disease	7.99e-05	0.000582	CbGpPWpGaD
Formoterol—ADRB2—Signaling by GPCR—DRD1—Parkinson's disease	7.93e-05	0.000577	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—PENK—Parkinson's disease	7.9e-05	0.000575	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—MAG—Parkinson's disease	7.9e-05	0.000575	CbGpPWpGaD
Formoterol—ADRB2—GPCR downstream signaling—ADRBK1—Parkinson's disease	7.9e-05	0.000575	CbGpPWpGaD
Formoterol—ADRB1—Signaling by GPCR—DRD3—Parkinson's disease	7.85e-05	0.000571	CbGpPWpGaD
Formoterol—ADRB1—GPCR downstream signaling—HTR7—Parkinson's disease	7.82e-05	0.000569	CbGpPWpGaD
Formoterol—ADRB1—GPCR downstream signaling—DRD2—Parkinson's disease	7.82e-05	0.000569	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—NDUFB11—Parkinson's disease	7.81e-05	0.000569	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—MAG—Parkinson's disease	7.73e-05	0.000563	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—PENK—Parkinson's disease	7.73e-05	0.000563	CbGpPWpGaD
Formoterol—ADRB2—Signaling by GPCR—DRD3—Parkinson's disease	7.68e-05	0.000559	CbGpPWpGaD
Formoterol—ADRB2—GPCR downstream signaling—DRD2—Parkinson's disease	7.65e-05	0.000557	CbGpPWpGaD
Formoterol—ADRB2—GPCR downstream signaling—HTR7—Parkinson's disease	7.65e-05	0.000557	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—OMD—Parkinson's disease	7.58e-05	0.000552	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—TALDO1—Parkinson's disease	7.58e-05	0.000552	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—GSTA4—Parkinson's disease	7.55e-05	0.00055	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—TALDO1—Parkinson's disease	7.51e-05	0.000547	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—OMD—Parkinson's disease	7.51e-05	0.000547	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—GCH1—Parkinson's disease	7.45e-05	0.000542	CbGpPWpGaD
Formoterol—ADRB1—Signaling by GPCR—ADRBK1—Parkinson's disease	7.33e-05	0.000534	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—PDYN—Parkinson's disease	7.23e-05	0.000526	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—NDUFB11—Parkinson's disease	7.19e-05	0.000523	CbGpPWpGaD
Formoterol—ADRB2—Signaling by GPCR—ADRBK1—Parkinson's disease	7.17e-05	0.000522	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—NDUFB11—Parkinson's disease	7.12e-05	0.000518	CbGpPWpGaD
Formoterol—ADRB1—Signaling by GPCR—DRD2—Parkinson's disease	7.1e-05	0.000517	CbGpPWpGaD
Formoterol—ADRB1—Signaling by GPCR—HTR7—Parkinson's disease	7.1e-05	0.000517	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—PDYN—Parkinson's disease	7.07e-05	0.000515	CbGpPWpGaD
Formoterol—ADRB2—Signaling by GPCR—DRD2—Parkinson's disease	6.94e-05	0.000505	CbGpPWpGaD
Formoterol—ADRB2—Signaling by GPCR—HTR7—Parkinson's disease	6.94e-05	0.000505	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—GCH1—Parkinson's disease	6.85e-05	0.000499	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—PLA2G6—Parkinson's disease	6.8e-05	0.000495	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—GFAP—Parkinson's disease	6.8e-05	0.000495	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—GCH1—Parkinson's disease	6.8e-05	0.000495	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—MAOB—Parkinson's disease	6.73e-05	0.00049	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	6.72e-05	0.000489	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—GRM5—Parkinson's disease	6.72e-05	0.000489	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—GFAP—Parkinson's disease	6.65e-05	0.000484	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—FBP1—Parkinson's disease	6.64e-05	0.000483	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—DBH—Parkinson's disease	6.64e-05	0.000483	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—GBA—Parkinson's disease	6.64e-05	0.000483	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—GRM5—Parkinson's disease	6.57e-05	0.000478	CbGpPWpGaD
Formoterol—ADRB1—GPCR downstream signaling—EDN1—Parkinson's disease	6.26e-05	0.000456	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	6.13e-05	0.000446	CbGpPWpGaD
Formoterol—ADRB2—GPCR downstream signaling—EDN1—Parkinson's disease	6.12e-05	0.000446	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—FBP1—Parkinson's disease	6.11e-05	0.000445	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—GBA—Parkinson's disease	6.11e-05	0.000445	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—DBH—Parkinson's disease	6.11e-05	0.000445	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—DBH—Parkinson's disease	6.06e-05	0.000441	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—FBP1—Parkinson's disease	6.06e-05	0.000441	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—GBA—Parkinson's disease	6.06e-05	0.000441	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—FGF20—Parkinson's disease	5.89e-05	0.000429	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—FGF20—Parkinson's disease	5.76e-05	0.00042	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—ADORA2A—Parkinson's disease	5.71e-05	0.000416	CbGpPWpGaD
Formoterol—ADRB1—Signaling by GPCR—EDN1—Parkinson's disease	5.68e-05	0.000414	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—ADORA2A—Parkinson's disease	5.59e-05	0.000407	CbGpPWpGaD
Formoterol—ADRB2—Signaling by GPCR—EDN1—Parkinson's disease	5.56e-05	0.000405	CbGpPWpGaD
Formoterol—ADRB1—GPCR downstream signaling—HTR2A—Parkinson's disease	5.48e-05	0.000399	CbGpPWpGaD
Formoterol—ADRB2—GPCR downstream signaling—HTR2A—Parkinson's disease	5.36e-05	0.00039	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—INSR—Parkinson's disease	5.27e-05	0.000384	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—INSR—Parkinson's disease	5.16e-05	0.000375	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—CYP2D6—Parkinson's disease	5e-05	0.000364	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—FGB—Parkinson's disease	4.98e-05	0.000363	CbGpPWpGaD
Formoterol—ADRB1—Signaling by GPCR—HTR2A—Parkinson's disease	4.97e-05	0.000362	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—HTR1A—Parkinson's disease	4.96e-05	0.000361	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—CTGF—Parkinson's disease	4.91e-05	0.000357	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—TAC1—Parkinson's disease	4.88e-05	0.000355	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—DDC—Parkinson's disease	4.88e-05	0.000355	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—FGB—Parkinson's disease	4.88e-05	0.000355	CbGpPWpGaD
Formoterol—ADRB2—Signaling by GPCR—HTR2A—Parkinson's disease	4.86e-05	0.000354	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—HTR1A—Parkinson's disease	4.85e-05	0.000353	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—DRD1—Parkinson's disease	4.79e-05	0.000348	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—TAC1—Parkinson's disease	4.78e-05	0.000348	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—DRD1—Parkinson's disease	4.68e-05	0.000341	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—DRD3—Parkinson's disease	4.64e-05	0.000338	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—GSTA4—Parkinson's disease	4.6e-05	0.000335	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—CYP2E1—Parkinson's disease	4.58e-05	0.000333	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	4.55e-05	0.000331	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—DRD3—Parkinson's disease	4.54e-05	0.00033	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—NQO1—Parkinson's disease	4.52e-05	0.000329	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—DDC—Parkinson's disease	4.48e-05	0.000326	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—TH—Parkinson's disease	4.46e-05	0.000325	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—DDC—Parkinson's disease	4.45e-05	0.000324	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—ADRBK1—Parkinson's disease	4.33e-05	0.000315	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—CYCS—Parkinson's disease	4.28e-05	0.000312	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—ADRBK1—Parkinson's disease	4.24e-05	0.000308	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—GSTA4—Parkinson's disease	4.23e-05	0.000308	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—GSTA4—Parkinson's disease	4.2e-05	0.000306	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—DRD2—Parkinson's disease	4.19e-05	0.000305	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—HTR7—Parkinson's disease	4.19e-05	0.000305	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—PLA2G6—Parkinson's disease	4.15e-05	0.000302	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	4.14e-05	0.000302	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—MAOB—Parkinson's disease	4.1e-05	0.000299	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—HTR7—Parkinson's disease	4.1e-05	0.000299	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—DRD2—Parkinson's disease	4.1e-05	0.000299	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	3.91e-05	0.000284	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—PLA2G6—Parkinson's disease	3.81e-05	0.000278	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—COMT—Parkinson's disease	3.79e-05	0.000276	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—PLA2G6—Parkinson's disease	3.78e-05	0.000275	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—MAOB—Parkinson's disease	3.77e-05	0.000275	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—GSTP1—Parkinson's disease	3.77e-05	0.000275	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—MAOA—Parkinson's disease	3.76e-05	0.000274	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—MAOB—Parkinson's disease	3.74e-05	0.000272	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—HMOX1—Parkinson's disease	3.72e-05	0.000271	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—ABCB1—Parkinson's disease	3.57e-05	0.00026	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	3.56e-05	0.000259	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—IGF2—Parkinson's disease	3.51e-05	0.000256	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—GSTM1—Parkinson's disease	3.47e-05	0.000252	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—IGF2—Parkinson's disease	3.44e-05	0.00025	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—IGF1R—Parkinson's disease	3.4e-05	0.000247	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—EDN1—Parkinson's disease	3.36e-05	0.000244	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—IGF1R—Parkinson's disease	3.32e-05	0.000242	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—GPX1—Parkinson's disease	3.32e-05	0.000242	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—EDN1—Parkinson's disease	3.28e-05	0.000239	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—NGF—Parkinson's disease	3.09e-05	0.000225	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—MTHFR—Parkinson's disease	3.06e-05	0.000223	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—CYP2D6—Parkinson's disease	3.05e-05	0.000222	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—NGF—Parkinson's disease	3.02e-05	0.00022	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—CTGF—Parkinson's disease	2.99e-05	0.000218	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—HTR2A—Parkinson's disease	2.94e-05	0.000214	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—HTR2A—Parkinson's disease	2.87e-05	0.000209	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—APOE—Parkinson's disease	2.85e-05	0.000208	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—CYP2E1—Parkinson's disease	2.79e-05	0.000203	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—CYP2D6—Parkinson's disease	2.78e-05	0.000202	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—NQO1—Parkinson's disease	2.76e-05	0.000201	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—CTGF—Parkinson's disease	2.75e-05	0.0002	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—APOE—Parkinson's disease	2.73e-05	0.000199	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—CTGF—Parkinson's disease	2.73e-05	0.000199	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—TH—Parkinson's disease	2.72e-05	0.000198	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—APOE—Parkinson's disease	2.67e-05	0.000194	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—CYCS—Parkinson's disease	2.61e-05	0.00019	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—CYP2E1—Parkinson's disease	2.57e-05	0.000187	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—CYP2E1—Parkinson's disease	2.54e-05	0.000185	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—NQO1—Parkinson's disease	2.54e-05	0.000185	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—NQO1—Parkinson's disease	2.51e-05	0.000183	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—TH—Parkinson's disease	2.5e-05	0.000182	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—TH—Parkinson's disease	2.48e-05	0.00018	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—INS—Parkinson's disease	2.44e-05	0.000177	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—CYCS—Parkinson's disease	2.4e-05	0.000175	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—CYCS—Parkinson's disease	2.38e-05	0.000173	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—INS—Parkinson's disease	2.33e-05	0.00017	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—COMT—Parkinson's disease	2.31e-05	0.000168	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—GSTP1—Parkinson's disease	2.3e-05	0.000167	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—MAOA—Parkinson's disease	2.3e-05	0.000167	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—INS—Parkinson's disease	2.28e-05	0.000166	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—HMOX1—Parkinson's disease	2.27e-05	0.000165	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—ABCB1—Parkinson's disease	2.18e-05	0.000158	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—COMT—Parkinson's disease	2.13e-05	0.000155	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—GSTP1—Parkinson's disease	2.12e-05	0.000154	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—GSTM1—Parkinson's disease	2.11e-05	0.000154	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—MAOA—Parkinson's disease	2.11e-05	0.000154	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—COMT—Parkinson's disease	2.11e-05	0.000153	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—GSTP1—Parkinson's disease	2.1e-05	0.000153	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—MAOA—Parkinson's disease	2.09e-05	0.000152	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—HMOX1—Parkinson's disease	2.09e-05	0.000152	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—HMOX1—Parkinson's disease	2.07e-05	0.000151	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—GPX1—Parkinson's disease	2.02e-05	0.000147	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—ABCB1—Parkinson's disease	2e-05	0.000146	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—ABCB1—Parkinson's disease	1.99e-05	0.000145	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—GSTM1—Parkinson's disease	1.94e-05	0.000142	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—GSTM1—Parkinson's disease	1.93e-05	0.00014	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—MTHFR—Parkinson's disease	1.87e-05	0.000136	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—GPX1—Parkinson's disease	1.86e-05	0.000136	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—GPX1—Parkinson's disease	1.85e-05	0.000134	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—APOE—Parkinson's disease	1.74e-05	0.000127	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—CASP3—Parkinson's disease	1.74e-05	0.000126	CbGpPWpGaD
Formoterol—ADRB1—Signaling by GPCR—IL6—Parkinson's disease	1.73e-05	0.000126	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—MTHFR—Parkinson's disease	1.72e-05	0.000125	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—MTHFR—Parkinson's disease	1.7e-05	0.000124	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—CASP3—Parkinson's disease	1.7e-05	0.000124	CbGpPWpGaD
Formoterol—ADRB2—Signaling by GPCR—IL6—Parkinson's disease	1.69e-05	0.000123	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—APOE—Parkinson's disease	1.6e-05	0.000116	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—MAPK8—Parkinson's disease	1.6e-05	0.000116	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—APOE—Parkinson's disease	1.59e-05	0.000115	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—MAPK8—Parkinson's disease	1.56e-05	0.000114	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—INS—Parkinson's disease	1.49e-05	0.000108	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—INS—Parkinson's disease	1.37e-05	9.95e-05	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—INS—Parkinson's disease	1.35e-05	9.86e-05	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—IL6—Parkinson's disease	1.02e-05	7.42e-05	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—IL6—Parkinson's disease	9.97e-06	7.26e-05	CbGpPWpGaD
